glp-1 weight loss drug news today 2025 Yearender: Health | After splash in 2025, weight-loss drugs poised to take off this year | Explained GLP-1 Drugs and Weight Loss:

The study was recently published in the medical journal JAMA Network Open

Endocrine reviews, vol

Despite margin pressures, Hims noted that it has shipped more than 125,000 Wegovy shots and pills in just six weeks, and that its projected to add 100,000 new weight loss subscribers per month

(26) GLP-1 agonists also demonstrated consistent reductions in lower limb amputation risk across subgroups, including those with peripheral arterial disease (PAD) and patients on antihypertensive therapy

Consequently, a better ability to intensify treatment upon failure, presumably because of tighter control, may add to the long-term efficacy of GLP-1RA and improved outcomes for patients